| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.04 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |